BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8012960)

  • 1. Development and characterization of nontumorigenic and tumorigenic epithelial cell lines from rat dorsal-lateral prostate.
    Danielpour D; Kadomatsu K; Anzano MA; Smith JM; Sporn MB
    Cancer Res; 1994 Jul; 54(13):3413-21. PubMed ID: 8012960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and characterization of DP-153, a nontumorigenic prostatic cell line that undergoes malignant transformation by expression of dominant-negative transforming growth factor beta receptor type II.
    Song K; Cornelius SC; Danielpour D
    Cancer Res; 2003 Aug; 63(15):4358-67. PubMed ID: 12907605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of transforming growth factor-beta autocrine activity by all-trans-retinoic acid and 1 alpha,25-dihydroxyvitamin D3 in NRP-152 rat prostatic epithelial cells.
    Danielpour D
    J Cell Physiol; 1996 Jan; 166(1):231-9. PubMed ID: 8557772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of active TGF-beta by prostatic cell cocultures using novel basal and luminal prostatic epithelial cell lines.
    Salm SN; Koikawa Y; Ogilvie V; Tsujimura A; Coetzee S; Moscatelli D; Moore E; Lepor H; Shapiro E; Sun TT; Wilson EL
    J Cell Physiol; 2000 Jul; 184(1):70-9. PubMed ID: 10825235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of responsiveness to transforming growth factor beta induces malignant transformation of nontumorigenic rat prostate epithelial cells.
    Tang B; de Castro K; Barnes HE; Parks WT; Stewart L; Böttinger EP; Danielpour D; Wakefield LM
    Cancer Res; 1999 Oct; 59(19):4834-42. PubMed ID: 10519393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of transforming growth factor-beta1, -beta2, and -beta3 in androgen-responsive growth of NRP-152 rat prostatic epithelial cells.
    Lucia MS; Sporn MB; Roberts AB; Stewart LV; Danielpour D
    J Cell Physiol; 1998 May; 175(2):184-92. PubMed ID: 9525477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cell lines as an in vitro/in vivo model for prostate carcinogenesis and progression.
    Webber MM; Quader ST; Kleinman HK; Bello-DeOcampo D; Storto PD; Bice G; DeMendonca-Calaca W; Williams DE
    Prostate; 2001 Apr; 47(1):1-13. PubMed ID: 11304724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered growth regulation and loss of response to retinoic acid accompany tumorigenic transformation of prostatic cells.
    Peehl DM; Sellers RG; Arnstein P; Kung HF; Rhim JS
    Anticancer Res; 1999; 19(5B):3857-64. PubMed ID: 10628324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells.
    Gao J; Arnold JT; Isaacs JT
    Cancer Res; 2001 Jul; 61(13):5038-44. PubMed ID: 11431338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of apoptosis induced by transforming growth factor-beta1 in nontumorigenic rat prostatic epithelial cell lines.
    Hsing AY; Kadomatsu K; Bonham MJ; Danielpour D
    Cancer Res; 1996 Nov; 56(22):5146-9. PubMed ID: 8912849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigallocatechin-3-gallate and bicalutamide cause growth arrest and apoptosis in NRP-152 and NRP-154 prostate epithelial cells.
    Morrissey C; Brown M; O'Sullivan J; Weathered N; Watson RW; Tenniswood M
    Int J Urol; 2007 Jun; 14(6):545-51. PubMed ID: 17593102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel human cell culture model for the study of familial prostate cancer.
    Yasunaga Y; Nakamura K; Ewing CM; Isaacs WB; Hukku B; Rhim JS
    Cancer Res; 2001 Aug; 61(16):5969-73. PubMed ID: 11507036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications. Part I. Cell markers and immortalized nontumorigenic cell lines.
    Webber MM; Bello D; Quader S
    Prostate; 1996 Dec; 29(6):386-94. PubMed ID: 8977636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen and prostatic stroma.
    Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G
    Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of TGF-beta 1, TGF-alpha, and EGF on cell proliferation and cell death in rat ventral prostatic epithelial cells in culture.
    Ilio KY; Sensibar JA; Lee C
    J Androl; 1995; 16(6):482-90. PubMed ID: 8867596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment of an immortalized Copenhagen rat prostate epithelial cell line.
    Yamazaki K; Pienta KJ
    In Vivo; 1995; 9(5):427-32. PubMed ID: 8900919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel human cancer culture model for the study of prostate cancer.
    Yasunaga Y; Nakamura K; Ko D; Srivastava S; Moul JW; Sesterhenn IA; McLeod DG; Rhim JS
    Oncogene; 2001 Nov; 20(55):8036-41. PubMed ID: 11753687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptor-mediated autocrine and paracrine stimulation of human transitional cell carcinoma.
    Gleave ME; Hsieh JT; Wu HC; Hong SJ; Zhau HE; Guthrie PD; Chung LW
    Cancer Res; 1993 Nov; 53(21):5300-7. PubMed ID: 8221665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of smooth muscle cell phenotype in cultured human prostatic stromal cells.
    Peehl DM; Sellers RG
    Exp Cell Res; 1997 May; 232(2):208-15. PubMed ID: 9168795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant transformation in a nontumorigenic human prostatic epithelial cell line.
    Hayward SW; Wang Y; Cao M; Hom YK; Zhang B; Grossfeld GD; Sudilovsky D; Cunha GR
    Cancer Res; 2001 Nov; 61(22):8135-42. PubMed ID: 11719442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.